1. Home
  2. ALCO vs ADCT Comparison

ALCO vs ADCT Comparison

Compare ALCO & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALCO
  • ADCT
  • Stock Information
  • Founded
  • ALCO 1960
  • ADCT 2011
  • Country
  • ALCO United States
  • ADCT Switzerland
  • Employees
  • ALCO N/A
  • ADCT N/A
  • Industry
  • ALCO
  • ADCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALCO
  • ADCT Health Care
  • Exchange
  • ALCO Nasdaq
  • ADCT Nasdaq
  • Market Cap
  • ALCO 238.8M
  • ADCT 241.0M
  • IPO Year
  • ALCO N/A
  • ADCT 2020
  • Fundamental
  • Price
  • ALCO $32.26
  • ADCT $2.71
  • Analyst Decision
  • ALCO
  • ADCT Strong Buy
  • Analyst Count
  • ALCO 0
  • ADCT 6
  • Target Price
  • ALCO N/A
  • ADCT $7.80
  • AVG Volume (30 Days)
  • ALCO 56.4K
  • ADCT 1.0M
  • Earning Date
  • ALCO 08-04-2025
  • ADCT 08-05-2025
  • Dividend Yield
  • ALCO 0.61%
  • ADCT N/A
  • EPS Growth
  • ALCO N/A
  • ADCT N/A
  • EPS
  • ALCO N/A
  • ADCT N/A
  • Revenue
  • ALCO $49,419,000.00
  • ADCT $75,817,000.00
  • Revenue This Year
  • ALCO $22.90
  • ADCT $10.65
  • Revenue Next Year
  • ALCO N/A
  • ADCT $15.05
  • P/E Ratio
  • ALCO N/A
  • ADCT N/A
  • Revenue Growth
  • ALCO 23.36
  • ADCT 10.49
  • 52 Week Low
  • ALCO $24.23
  • ADCT $1.05
  • 52 Week High
  • ALCO $34.08
  • ADCT $4.13
  • Technical
  • Relative Strength Index (RSI)
  • ALCO 55.47
  • ADCT 46.56
  • Support Level
  • ALCO $31.00
  • ADCT $2.59
  • Resistance Level
  • ALCO $32.69
  • ADCT $2.98
  • Average True Range (ATR)
  • ALCO 0.68
  • ADCT 0.31
  • MACD
  • ALCO -0.07
  • ADCT -0.15
  • Stochastic Oscillator
  • ALCO 40.56
  • ADCT 8.70

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: